C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2006
10/26/2006	US20060239968 method of delivering agent to prostate cancer tissue comprising obtaining peptide that selectively binds to prostate cancer tissue, where peptide is less than 100 amino acids in length and includes prostate cancer targeting motif having disclosed amino acid sequence; peptide is attached to target agent
10/26/2006	US20060239912 Carrier molecules
10/26/2006	US20060239911 Antibodies with immune effector activity and that internalize in endosialin-positive cells
10/26/2006	US20060239910 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
10/26/2006	DE202005020828U1 New human antibody that is able to bind human CD152 or its antibody fragment, useful for treating tumor disease e.g. lung cancer, skin cancer, bone cancer, uterus cancer, ovarian cancer and stomach cancer
10/26/2006	CA2618721A1 Elimination of heterogeneous or mixed cell population in tumors
10/26/2006	CA2605964A1 High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies
10/26/2006	CA2605402A1 Antibody neutralizers of human granulocyte macrophage colony stimulating factor
10/26/2006	CA2605020A1 Method for treating inflammatory bowel disease (ibd) by an anti-cd20 antibody
10/26/2006	CA2604933A1 Methods and compositions for modulating and detecting wisp activity
10/26/2006	CA2604840A1 Stabilized anti-hepatitis b (hbv) antibody formulations
10/26/2006	CA2604675A1 Diagnostic and therapeutic potential of immune globulin intravenous (igiv) products
10/26/2006	CA2604604A1 Methods for treating and preventing fibrosis by il-21 / il-21r antagonists
10/26/2006	CA2604515A1 Toll-like receptor 14 (tlr14 ) and use thereof
10/26/2006	CA2604222A1 Il-21 variants
10/26/2006	CA2602635A1 Method of altering the binding specificity of proteins by oxidation-reduction reactions
10/25/2006	EP1715064A1 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses
10/25/2006	EP1715052A1 Composition and method for elevating gene transfer efficiency
10/25/2006	EP1715045A2 Recombinant antibodies for human therapy
10/25/2006	EP1715044A2 Human neurexin-like proteins and polynucleotides encoding the same
10/25/2006	EP1715043A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
10/25/2006	EP1715038A1 Antibody targeting osteoclast-associated protein
10/25/2006	EP1715035A2 Synthetic polynucleotides encoding lysyl oxidase
10/25/2006	EP1714982A2 Methods for purifying highly anionic proteins
10/25/2006	EP1714980A1 Human receptor proteins, related reagents and methods
10/25/2006	EP1714971A2 Directed switch-mediated DNA recombination
10/25/2006	EP1714152A2 Monoclonal antibody based biomarker discovery and development platform
10/25/2006	EP1713907A2 Hybrid proteins of active-site serine beta-lactamase.
10/25/2006	EP1713830A2 Anti-epcam immunoglobulins
10/25/2006	EP1713829A2 Antibody for diagnosing and treating neuropsychiatric diseases, in particular schizophrenia, depression and bipolar affective disorders
10/25/2006	EP1713827A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
10/25/2006	EP1713821A2 Primary central nervous system tumor specific behab isoforms
10/25/2006	EP1713503A1 Inhibition of factor b, the alternative complement pathway and methods related thereto
10/25/2006	EP1713502A1 Highly concentrated liquid formulations of anti-egfr antibodies
10/25/2006	EP1713494A2 Treatment of conditions involving dopaminergic neuronal degeneration using nogo receptor antagonists
10/25/2006	EP1713493A2 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use
10/25/2006	EP1423417B1 Antibodies recognizing a peptide mimicking a cryptic epitope of gp41 of hiv-1
10/25/2006	EP1401496B1 Compositions and methods for treating hyperimmune response in the eye
10/25/2006	EP1373308B1 Antagonist for multimerization of hiv-1 vif protein
10/25/2006	EP1332155B1 Immunization of dairy cattle with gapc protein against streptococcus infection
10/25/2006	EP1235805B1 Immunoassay for neonicotinyl insecticides
10/25/2006	EP1109901B1 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF
10/25/2006	EP1107993B1 Human monoclonal antibodies directed against the islet cell antigen ia-2
10/25/2006	EP1097167B1 Neurotrophic growth factor
10/25/2006	EP1016866B1 Novel compound 2-amino-3-[2-(alpha-mannopyranosyl) indol-3-yl] propionic acid, process for preparing the same, and method for inspecting function of living body with the novel compound
10/25/2006	CN1852985A Process for the production of fine chemicals
10/25/2006	CN1852981A The anti-platelet membrane glycoprotein VI monoclonal antibody
10/25/2006	CN1852980A Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist
10/25/2006	CN1852976A Binding constructs and methods for use thereof
10/25/2006	CN1852925A Humanized immunoglobulin loci
10/25/2006	CN1852924A PAN-KIR2DL NK-receptor antibodies and their use in diagnostik and therapy
10/25/2006	CN1852923A Human antibody molecules for IL-13
10/25/2006	CN1852922A Methods for ex vivo hybridoma-free production of polyclonal and monoclonal antibodies and generation of immortalized cell populations
10/25/2006	CN1852736A Immunoglobulin chimeric monomer-dimer hybrids
10/25/2006	CN1852730A Modulators of P-selectin glycoprotein ligand 1
10/25/2006	CN1850863A Antibody to self-antigen and/or intergeneric high conservative antigen, and its preparing method
10/25/2006	CN1850862A Chicken interleukin-2-receptor alpha chain extracellular region protein monoclonal antibody, and its preparing method
10/25/2006	CN1850861A Anti white spot virus adherent protein VP19 monocloral antibody, and its preparing method
10/25/2006	CN1850860A Antifish lymphocystis virus capsid protein monoclonal antibody, and its preparing method
10/25/2006	CN1281747C i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene
10/25/2006	CN1281626C Method and reagent kit for detecting and measuring 3,4-methylene methedrine (MDMA)
10/25/2006	CN1281622C Excreted proteins as indicators related to tumor and application
10/24/2006	US7125970 Host cells; drug screening; antigrowth agents
10/24/2006	US7125964 Using magnetic beads conjugated with major histocompatability complex peptides to purify and expand in vitro tumor- and virus-specific killer lymphocytes for use in cell therapy, tissue targeted therapy and engineering
10/24/2006	US7125962 Nucleotide sequences coding membrane protein for use in the treatment of cell proliferation disorders
10/24/2006	US7125961 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
10/24/2006	US7125959 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
10/24/2006	US7125714 Progenitor cell materials and methods
10/24/2006	US7125713 Human mullerian duct-derived epithelial cells and methods of isolation and uses thereof
10/24/2006	US7125699 for treating solid tumours, macular degeneration, corneal rejection, psoriasis, rheumatoid arthritis and chronic ulceration, and diseases involving vascular insufficiency, including stroke and following heart attack
10/24/2006	US7125697 Expression vector containing the polynucleotide; cell transformation; use in diganostics and as substrate for luminescent reactions; coelenterazine
10/24/2006	US7125689 Method for rendering streptokinase less immunogenic to a human
10/24/2006	US7125686 Proteins and methods for producing the proteins
10/24/2006	US7125684 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER)
10/24/2006	US7125681 Diagnosing cancer in humans; obtain urine, incubate with antibody, detect complex formation, the presence of complex indicates cancer disorders
10/24/2006	US7125678 Protein biopolymer markers predictive of type II diabetes
10/24/2006	US7125670 Comprises activated CD4 T-cells (ACT-4-L) ligand polypeptide for detection of immunomodulators; autoimmune diseases; drug screening; immunosuppressants; viricides
10/24/2006	US7125663 Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
10/24/2006	US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein
10/24/2006	US7125554 Engineered superantigen for human therapy
10/24/2006	US7125552 Glycine extraction of a water and ethanol suspension of the immunoglobulins, followed by anion exchange chromatography to achieve a significantly high yield and high purity
10/24/2006	US7125551 Compound for use inthe diagnosis and treatment of cancer, viral, asthmatic, autoimmune, organ transplant rejection and infections
10/24/2006	US7125550 Play a role in capacitation of sperm and the fertilization of the ovum and make ideal targets for the design of contraceptive agents.
10/24/2006	US7125541 Administering targeting agent operatively attached to a therapeutic agent, and wherein the targeting agent recognizes and binds to a tumor-associated endothelial cell marker
10/19/2006	WO2006110760A2 Compositions and methods for the diagnosis and treatment of tumor
10/19/2006	WO2006110745A2 Conjugated anti-psma antibodies
10/19/2006	WO2006110582A1 Compositions and methods for the treatment of burns and sepsis
10/19/2006	WO2006110367A2 Methods and compositions for mycoplasma toxins
10/19/2006	WO2006110292A2 Temperature-triggered immobilization and purification of antibodies
10/19/2006	WO2006109781A1 Process for production of glycoprotein composition
10/19/2006	WO2006109599A1 Antibody reactive specifically to age derived from 3,4-dge
10/19/2006	WO2006109592A1 Antibody substituting for function of blood coagulation factor viii
10/19/2006	WO2006109071A2 Vaccine against burkholderia infections
10/19/2006	WO2006109045A2 Cathepsin s antibody
10/19/2006	WO2006108670A2 Use of cd25 antibodies in immunotherapy
10/19/2006	WO2006108627A1 Anti-egfr antibody therapy based on an increased copy number of the egfr gene in tumor tissues
10/19/2006	WO2006108234A1 Modified animal lacking functional pyy gene, monoclonal antibodies that bind pyy isoforms and uses therefor
10/19/2006	WO2006094134A3 Kim-1 antibodies for treatment of th2-mediated conditions
10/19/2006	WO2006091824A3 Peptides for detection of antibody to porcine reproductive respiratory syndrome virus
10/19/2006	WO2006083689A3 Anti a beta antibody formulation

1 ... 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 ... 1494